Management of oral and gastrointestinal mucosal injury: ESMO Clinical Practice Guidelines for diagnosis, treatment, and follow-up

Incidence and time course of everolimus-related adverse events in postmenopausal women with hormone receptor-positive advanced breast cancer: insights from BOLERO-2

(2014) H. S. Rugo et al.   ANNALS OF ONCOLOGY

MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy

(2014) Rajesh V. Lalla et al.   CANCER

Clinical nutrition guidelines of the French Speaking Society of Clinical Nutrition and Metabolism (SFNEP): Summary of recommendations for adults undergoing non-surgical anticancer treatment

(2014) Pierre Senesse et al.   DIGESTIVE AND LIVER DISEASE

Référentiel de pratiques professionnelles : prise en charge nutritionnelle des cancers des voies aérodigestives supérieures

(2014) Patrick Bachmann et al.   Nutrition Clinique et Metabolisme

Polymorphisms in Radio-Responsive Genes and Its Association with Acute Toxicity among Head and Neck Cancer Patients

(2014) Goutham Hassan Venkatesh et al.   PLoS One

Targeted therapy-induced diarrhea: A review of the literature

(2013) M.A. Pessi et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Mammalian target of rapamycin inhibitor-associated stomatitis

(2013) Christine B Boers-Doets et al.   Future Oncology

Oral mucosal injury caused by cancer therapies: current management and new frontiers in research

(2013) Siri B. Jensen et al.   JOURNAL OF ORAL PATHOLOGY & MEDICINE

SNP-based Bayesian networks can predict oral mucositis risk in autologous stem cell transplant recipients

(2013) ST Sonis et al.   ORAL DISEASES

Risk of oral and gastrointestinal mucosal injury among patients receiving selected targeted agents: a meta-analysis

(2013) Linda S. Elting et al.   SUPPORTIVE CARE IN CANCER

Systematic review of basic oral care for the management of oral mucositis in cancer patients

(2013) Deborah B. McGuire et al.   SUPPORTIVE CARE IN CANCER

New developments in management of oral mucositis in patients with head and neck cancer or receiving targeted anticancer therapies

(2012) E. Li et al.   AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY

Enteral Feeding Tubes in Patients Undergoing Definitive Chemoradiation Therapy for Head-and-Neck Cancer: A Critical Review

(2012) Shlomo A. Koyfman et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Management of oral and gastrointestinal mucositis: ESMO Clinical Practice Guidelines

(2011) D. E. Peterson et al.   ANNALS OF ONCOLOGY

Impact of prophylactic percutaneous endoscopic gastrostomy on malnutrition and quality of life in patients with head and neck cancer - a randomized study

(2011) Ewa Silander et al.   HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK

Vanderbilt head and neck symptom survey version 2.0: Report of the development and initial testing of a subscale for assessment of oral health

(2011) Emily Cooperstein et al.   HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK

Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial

(2011) Christopher M Nutting et al.   LANCET ONCOLOGY

Oral Adverse Events Associated with Tyrosine Kinase and Mammalian Target of Rapamycin Inhibitors in Renal Cell Carcinoma: A Structured Literature Review

(2011) C. B. Boers-Doets et al.   ONCOLOGIST

Clinical presentation and management of mTOR inhibitor-associated stomatitis

(2011) Marcio Augusto de Oliveira et al.   ORAL ONCOLOGY

Oral complications of targeted cancer therapies: A narrative literature review

(2011) A.L. Watters et al.   ORAL ONCOLOGY

Enteral feeding outcomes after chemoradiotherapy for oropharynx cancer: A role for a prophylactic gastrostomy?

(2011) Gillian F. Williams et al.   ORAL ONCOLOGY

Impact of early percutaneous endoscopic gastrostomy tube placement on nutritional status and hospitalization in patients with head and neck cancer receiving definitive chemoradiation therapy

(2010) Charles E. Rutter et al.   HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK

Staphylococcus Coagulase-Positive Skin Inflammation Associated with Epidermal Growth Factor Receptor-Targeted Therapy: An Early and a Late Phase of Papulopustular Eruptions

(2010) I. Amitay-Laish et al.   ONCOLOGIST

FDA Approval Summary: Temsirolimus as Treatment for Advanced Renal Cell Carcinoma

(2010) V. E. Kwitkowski et al.   ONCOLOGIST

The potential successes and challenges of targeted anticancer therapies

(2010) Dorothy Keefe et al.   Current Opinion in Supportive and Palliative Care

Dermatologic Infections in Cancer Patients Treated With Epidermal Growth Factor Receptor Inhibitor Therapy

(2009) R. E. Eilers et al.   JNCI-Journal of the National Cancer Institute

Clinical Efficacy and Toxicity of Anti-EGFR Therapy in Common Cancers

(2009) Amir Harandi et al.   Journal of Oncology

EGFR Inhibitor-Associated Acneiform Folliculitis

(2008) Madeleine Duvic   AMERICAN JOURNAL OF CLINICAL DERMATOLOGY

Handling side-effects of targeted therapies: safety of targeted therapies in solid tumours

(2008) E. Elez et al.   ANNALS OF ONCOLOGY

Clinical Management of Patients Receiving Tyrosine Kinase Inhibitors for Advanced Renal Cell Carcinoma

(2008) Jan Roigas   EUROPEAN UROLOGY SUPPLEMENTS

Activation of the VEGFR-3 Pathway by VEGF-C Attenuates UVB-Induced Edema Formation and Skin Inflammation by Promoting Lymphangiogenesis

(2008) Kentaro Kajiya et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY